BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24379667)

  • 1. Fullerene-biomolecule conjugates and their biomedicinal applications.
    Yang X; Ebrahimi A; Li J; Cui Q
    Int J Nanomedicine; 2014; 9():77-92. PubMed ID: 24379667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery.
    Mallick S; Choi JS
    J Nanosci Nanotechnol; 2014 Jan; 14(1):755-65. PubMed ID: 24730295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fullerene-derivatized amino acids: synthesis, characterization, antioxidant properties, and solid-phase peptide synthesis.
    Yang J; Alemany LB; Driver J; Hartgerink JD; Barron AR
    Chemistry; 2007; 13(9):2530-45. PubMed ID: 17236230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phase transition temperature of liposomes on preparation of fullerene-encapsulated liposomes by the fullerene-exchange reaction.
    Ikeda A; Kawai Y; Kikuchi J; Akiyama M
    Chem Commun (Camb); 2010 Apr; 46(16):2847-9. PubMed ID: 20369203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal applications of fullerenes.
    Bakry R; Vallant RM; Najam-ul-Haq M; Rainer M; Szabo Z; Huck CW; Bonn GK
    Int J Nanomedicine; 2007; 2(4):639-49. PubMed ID: 18203430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological application of glyco- and peptide derivatives of fullerene C
    Tanzi L; Terreni M; Zhang Y
    Eur J Med Chem; 2022 Feb; 230():114104. PubMed ID: 35051749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Decoration of [60]Fullerene with Polymannan Analogues and Amino Acid Derivatives through Malondiamide-Based Linkers.
    Tanzi L; Rubes D; Bavaro T; Sollogoub M; Serra M; Zhang Y; Terreni M
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fullerene-conjugated doxorubicin in cells.
    Liu JH; Cao L; Luo PG; Yang ST; Lu F; Wang H; Meziani MJ; Haque SA; Liu Y; Lacher S; Sun YP
    ACS Appl Mater Interfaces; 2010 May; 2(5):1384-9. PubMed ID: 20420365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antioxidant activity of [60]fullerene-BHT conjugates.
    Enes RF; Tomé AC; Cavaleiro JA; Amorati R; Fumo MG; Pedulli GF; Valgimigli L
    Chemistry; 2006 Jun; 12(17):4646-53. PubMed ID: 16534828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fullerene sugar balls: a new class of biologically active fullerene derivatives.
    Nierengarten I; Nierengarten JF
    Chem Asian J; 2014 Jun; 9(6):1436-44. PubMed ID: 24678063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
    Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
    Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fullerene derivatives: an attractive tool for biological applications.
    Bosi S; Da Ros T; Spalluto G; Prato M
    Eur J Med Chem; 2003; 38(11-12):913-23. PubMed ID: 14642323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant Properties of Fullerene Derivatives Depend on Their Chemical Structure: A Study of Two Fullerene Derivatives on HELFs.
    Sergeeva V; Kraevaya O; Ershova E; Kameneva L; Malinovskaya E; Dolgikh O; Konkova M; Voronov I; Zhilenkov A; Veiko N; Troshin P; Kutsev S; Kostyuk S
    Oxid Med Cell Longev; 2019; 2019():4398695. PubMed ID: 30800207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal formulation of amphiphilic fullerene antioxidants.
    Zhou Z; Lenk RP; Dellinger A; Wilson SR; Sadler R; Kepley CL
    Bioconjug Chem; 2010 Sep; 21(9):1656-61. PubMed ID: 20839887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon nanomaterials: Biologically active fullerene derivatives.
    Bogdanović G; Djordjević A
    Srp Arh Celok Lek; 2016; 144(3-4):222-31. PubMed ID: 27483572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.
    Johnston HJ; Hutchison GR; Christensen FM; Aschberger K; Stone V
    Toxicol Sci; 2010 Apr; 114(2):162-82. PubMed ID: 19901017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
    Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
    Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy.
    Guan M; Ge J; Wu J; Zhang G; Chen D; Zhang W; Zhang Y; Zou T; Zhen M; Wang C; Chu T; Hao X; Shu C
    Biomaterials; 2016 Oct; 103():75-85. PubMed ID: 27376559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization of fullerene C60 in micellar solutions of different solubilizers.
    Torres VM; Posa M; Srdjenovic B; Simplício AL
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):46-53. PubMed ID: 20828997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile access to novel [60]fullerenyl diethers and [60]fullerene-sugar conjugates via annulation of diol moieties.
    Zhai WQ; Jiang SP; Peng RF; Jin B; Wang GW
    Org Lett; 2015 Apr; 17(8):1862-5. PubMed ID: 25824470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.